Boston Scientific Corporation vs Campbell Soup Co. — how do they compare? Boston Scientific Corporation trades at $51 (market cap $71.46B), while Campbell Soup Co. trades at $22.79 (market cap $6.69B). The key difference: Boston Scientific Corporation is far larger — about 10.7× Campbell Soup Co.'s market cap, and Campbell Soup Co. pays a 6.96% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | CPB | |
|---|---|---|
Market Cap | $71.46B | $6.69B |
Sector | Health | Consumer Staples |
52-Week High | $108.14 | $34.03 |
52-Week Low | $42.63 | $20.00 |
Enterprise Value | $83.55B | $13.29B |
Dividend Yield | — | 6.96% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Read more on CPB →